FOSTER CITY, Calif.--(BUSINESS WIRE)--OXIS International Inc (OTCBB: OXIS), a biopharmaceutical company focused on commercializing predictive biomarkers, clinical assays and neutraceutical and therapeutic products, announced that Marvin S. Hausman MD, its President and CEO, is scheduled to present at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference on Monday, May 14, at 4:20 p.m. local time (10:20 a.m. Eastern time). Dr. Hausman is expected to present an update on the Company’s L-ergothioneine (ERGO) Program, The conference is being held at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.
